Sharawat et al. evaluated CD135 and CD117 expressions in a cohort of 115 AML patients (64 pediatric and 51 adults) and showed that CD135 was expressed in 82% of all cases. This evidence concerns the gene FLT3 and acute myeloid leukemia.